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The intracellular mechanisms involved in the early phase of dendritic cell (DC) activation upon contact
with chemical sensitizers are not well known. The strong skin sensitizer 2,4-dinitrofluorobenzene (DNFB) was
shown to induce the activation of mitogen-activated protein kinases (MAPK) in DC. In the present study, we
investigated a putative role for oxidative stress in DNFB-induced MAPK activation and upregulation of the
costimulatory molecule CD40. In a DC line generated from fetal mouse skin, DNFB induced a significant increase
in protein oxidation, measured by the formation of carbonyl groups, while it had almost no effect on lipid
peroxidation. The antioxidants glutathione and vitamin E, which inhibit protein and lipid oxidation, respectively,
were used to assess the role of oxidative stress in DNFB-induced MAPK activation. Glutathione, but not vitamin E,
inhibited DNFB-induced p38 MAPK and ERK1/2 phosphorylation, whereas none of the antioxidants interfered
significantly with the DNFB-induced upregulation of CD40 protein levels. Taken together, these results indicate that
DNFB activates p38 MAPK and ERK1/2 via production of reactive oxygen species, and that protein oxidation plays








When activated by haptens, DC in the skin lose their antigen





 In this process, DC switch chemokine
receptors, alter cytokine production, and upregulate the
expression of MHC molecules and costimulatory molecules









in cultures of DC, which in the presence of skin sensitizers





have shown in the fetal skin derived dendritic cell (FSDC)








 CD40, a member of the TNF
receptor (TNFR) family, is a 45–50 kDa receptor expressed





antigen presentation, the interaction of CD40 in DC with its
ligand (CD40L) on activated T cells is critical for DC matura-
tion, and it induces IL-12 production, leading to the differen-




 Several skin sensitizers have
been shown to upregulate CD40 protein expression on DC,
such as 2,4,6-trinitrobenzene sulphonic acid (TNBS), amino-
phenol, chlorpromazine hydrochloride, dinitrochlorobenzene




The exact cellular and molecular mechanisms of DC
activation by haptens remain poorly understood. Reactive
oxygen species (ROS) are normally produced by phagocytic
cells, such as macrophages, when NADPH oxidase is acti-





evidence suggests that they may play an essential role in
signal transduction. In addition to apoptosis, free radicals and
derived species regulate many cellular events, including
transcription factor activation, gene expression and cell pro-




Several reports have shown, in different cell types, that
oxidants activate intracellular signalling pathways (e.g.





role for ROS as second messengers. Activation of MAPK has









 activate p38 high osmolarity









DNCB was also shown to activate p38 MAPK in the imma-




In the present work, we found that the strong sensitizer
DNFB also activates ERK1/2 and p38 MAPK in FSDC. To
clarify some of the signalling events involved in skin DC
activation upon contact with chemical sensitizers, we investi-
gated whether MAPK activation was dependent on ROS
formation. The role of ROS in the regulation of CD40






Trypsin was purchased from Gibco-Invitrogen (Life Technologies,
Paisley, UK). FCS was from Cambrex (Walkersville, MD, USA).
DNFB and 2,4-dichloronitrobenzene (DCNB) were from Aldrich
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(Madrid, Spain). The antibody against phospho-ERK1/2 was from
Promega (Madison, WI, USA). The anti-phospho-p38 MAPK anti-
body was from Cell Signalling Technology (Beverly, MA, USA),
and the antibody against dinitrophenyl (DNP) was from Dako
(Glostrup, Denmark). The anti-CD40 antibody was purchased
from R&D Systems (Minneapolis, MN, USA). The alkaline
phosphatase-linked goat antirabbit IgG (H + L) antibody and the
enhanced chemifluorescence (ECF) substrate were purchased
from Amersham Biosciences (Carnaxide, Portugal), and the alka-
line phosphatase-linked goat antirat IgG (H + L) antibody was
purchased from Chemicon (Temecula, CA, USA). All other reagents





The FSDC line, kindly supplied by Dr G. Girolomoni, was estab-
lished from fetal mouse skin suspensions and is representative of an




 This cell line is activated




 and upon activa-












C in a humidified atmosphere of




, in Iscove modified Dulbecco’s medium
(IMDM; Sigma) supplemented with 10% heat inactivated FCS,
36 mmol/L sodium bicarbonate, 64.4 mmol/L glutamine, 100 U/mL




g/mL streptomycin. Cells were fed with fresh












 cells/well in six-well microplates for








 cells/well in 12-well microplates
for lipid peroxidation assays, and they were grown for 2 days or
1 day, respectively. Cells were then maintained in serum-free IMDM
for 10–30 min, before addition of the strong sensitizer DNFB or of its









 and does not
reduce cell viability under the experimental conditions used, as
determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazo-
lium bromide (MTT) and 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-
5-tetrazolio]-1-3-benzene disulfonate (WST-1) assays (data not




C for different periods of time
(as indicated in the figure captions). Inhibition of protein and lipid
oxidation was performed by adding 1 mmol/L glutathione (GSH) or
1 mmol/L vitamin E, respectively, to the stimulation medium. In this
case, the cells were preincubated with the antioxidants for 90 min




After stimulation, cells were washed with ice-cold PBS and scraped
into ice-cold lysis buffer containing protease and phosphatase
inhibitors (50 mmol/L HEPES [pH 7.5], 1% Triton X-100,





































protein determination using the bicinchoninic acid (BCA) protein
assay method (Pierce, Rockford, IL, USA). Cell lysates were then




 sample buffer (187.5 mmol/L Tris-HCl





-mercaptoethanol) and either used immediately for




C until use. Cell lysates
for anti-CD40 western blots were prepared with the same solutions




Western blotting was performed for the analysis of ERK, JNK and
p38 MAPK activation (using antibodies specific for the phosphory-
lated form of the three kinases) and for the analysis of CD40 protein





onto a 10% SDS–polyacrylamide gel, subjected to electrophoresis,
and transferred to polyvinylidene difluoride (PVDF) membranes
(Amersham Biosciences). The membranes were saturated with 5%
(w/v) fat-free dry milk in Tris-buffered saline (50 mmol/L Tris
[pH 8.0], 150 mmol/L NaCl) with 0.1% Tween 20 (TBS-T) for
90 min at room temperature. Blots were then incubated overnight
with primary antibodies at 1:1000 or 1:5000 dilution for phospho-p38
MAPK and phospho-ERK, respectively. Incubation with the anti-
body against CD40 (1:500) was performed for 2 h at room
temperature. The solutions of primary antibodies were prepared in
1% fat-free dry milk in TBS-T. After extensive washing with 0.5%
fat-free dry milk in TBS-T, blots were further incubated for 1 h at
room temperature with goat antirabbit or antirat IgG antibodies
coupled to alkaline phosphatase, at 1:20 000 or 1:10 000 dilution,
respectively, in 1% fat-free dry milk in TBS-T. Blots were then
washed in 0.5% fat-free dry milk in TBS-T. The immune complexes
were detected using the ECF system (Amersham Biosciences),
and the membranes were then scanned for blue excited fluores-
cence on the Storm 860 (Amersham Biosciences), according to the
manufacturer’s instructions. The signals were analyzed using Image-
Quant software (Amersham Biosciences).
 
Derivatization of protein carbonyls and dot blot analysis
 
The FSDC, stimulated as described above, were washed with ice-cold
phosphate buffer (PBS) and scraped into ice-cold lysis buffer con-
taining protease and phosphatase inhibitors (300 mmol/L sucrose,
2 mmol/L EGTA, 10 mmol/L HEPES [pH 7.4], and freshly added
1 mmol/L DTT, 1 mmol/L PMSF and complete mini-tablet protease














protein determination using the BCA protein assay method (Pierce),




g) was derivatized by
adding one volume of 12% SDS and two volumes of 20 mmol/L
DNPH/10% trifluoroacetic acid (TFA), followed by a 30 min incuba-
tion at room temperature in the dark. Then 1.5 volumes of 2 mol/L




-mercaptoetanol was added to each
sample. Negative control experiments were done by processing one
sample as described, except for the omission of the 20 mmol/L





g) was then applied to a PVDF membrane. The membranes were
saturated with 5% (w/v) fat-free dry milk in TBS-T for 90 min at
room temperature. Blots were then incubated overnight with anti-
DNP primary antibodies at 1:500 000 dilution in 5% fat-free dry
milk in TBS-T. After extensive washing with 0.5% fat-free dry milk
in TBS-T solution, blots were further incubated for 1 h at room
temperature with goat anti-rabbit IgG antibodies coupled to alkaline
phosphatase (1:20 000 dilution) in 1% fat-free dry milk in TBS-T.
Blots were then washed in 0.5% fat-free dry milk in TBS-T. The
immune complexes were detected using the ECF system, as described
for western blots. The signals were analyzed using the ImageQuant
software (Amersham Biosciences).






The extent of peroxidation was determined by the thiobarbituric acid
(TBA) method. After stimulation, cells were washed with ice-cold
PBS and scraped in ice-cold 15 mmol/L Tris (pH 7.4). The samples
were then diluted three times with 15% trichloroacetic acid (TCA),


















C, the supernatants were
collected and the absorbance was measured at 530 nm on the UV/VIS
spectrophotometer Lambda 3B (Perkin-Elmer, Wellesley, MA, USA).
The amount of thiobarbituric acid-reactive substances (TBARS)









 mol/L per cm and expressed as nmol TBARS produced by
milligram of protein. The results were then expressed as fold increase
relative to the control. Protein was measured by the BCA protein assay




















 SEM of the indicated number of
independent experiments, and statistical analysis was performed









 with a Bonferroni’s post-test, as









DNFB induces protein oxidation but not lipid peroxidation
 
To assess whether DNFB induces any type of oxidative stress
in FSDC, we examined the content of oxidized proteins and





g/mL). The formation of carbonyl groups was
assessed to investigate protein oxidation, which could play a
role in signal transduction, and lipid peroxidation was evalu-
ated using the TBARS method.
FSDC cells were stimulated with DNFB for different
periods of time and the formation of carbonyl groups was
examined after derivatization, followed by dot blot analysis of
the derivatized groups (Fig. 1A). Protein oxidation increased
as soon as 5 min after exposure to DNFB, and further
increased 30 min after exposure to the sensitizer (Fig. 1A),
suggesting that DNFB induces the formation of ROS that can
mediate cellular signalling. The specificity of the sensitizing
effect of DNFB was tested using its inactive analogue,
2,4-dichloronitrobenzene (DCNB). In contrast with the results
observed with DNFB, DCNB did not affect the oxidation
of proteins (Fig. 1A).
In contrast to what we observed for protein oxidation,
DNFB did not induce significant lipid peroxidation (Fig. 1B),
suggesting that lipid peroxides are not the major free radicals












for 15 min significantly increased lipid peroxidation.
 
Gluthathione inhibits the DNFB-induced phosphorylation 
of ERK1/2 and p38 MAPK
 
Because activation of MAPK has been detected in DC upon





investigated whether protein oxidation plays a role in the
activation of these signalling pathways. As shown in Figure 2,
stimulation of FSDC with DNFB induced the phosphoryla-
tion (activation) of ERK1/2 and p38 MAPK, and this effect
was almost completely inhibited by adding reduced GSH,
which prevents protein oxidation. These results suggest that
protein oxidation plays an important role in the activation of
MAPK.
 
Vitamin E does not affect DNFB-induced phosphorylation 
of ERK1/2 and p38 MAPK
 
We further investigated whether lipid peroxidation could be
involved in MAPK activation. For this purpose, cells were
stimulated with DNFB, in the presence or in the absence of
vitamin E, a lipid-soluble antioxidant. Vitamin E did not
affect the phosphorylation of the MAPK induced by DNFB
(Fig. 3), in agreement with the results showing that DNFB
does not interfere with lipid peroxidation.
 
Role of protein and lipid oxidation in DNFB-induced 
upregulation of CD40 protein levels
 
To investigate the role of protein and lipid oxidation on the
activation and maturation of FSDC, we studied the effect of
gluthatione and vitamin E on the DNFB-induced upregulation
of CD40 protein levels. This maturation marker is involved in
the interaction of DC with T cells and is upregulated under





oxidants partly reduced the effect of the sensitizer on CD40
protein levels after 2 h of stimulation (Fig. 4), but although it
was consistent in all of the experiments performed, the





The major cellular events involved in DC activation and
maturation during the process of skin sensitization are still
unknown. Previous studies demonstrated that chemical sensi-





we show that ROS are involved in p38 MAPK and ERK1/2
activation in a skin derived DC line (FSDC) exposed to
subtoxic concentrations of the chemical sensitizer DNFB.
Furthermore, the DNFB-induced CD40 upregulation in
FSDC is largely independent of the ROS-induced signalling
pathways.
A growing amount of evidence suggests that ROS can




 In this study, we investigated
whether DNFB induces oxidative stress, particularly protein
oxidation and/or lipid peroxidation. We found that the sensi-
tizer significantly increased the oxidized protein content
(Fig. 1A), whereas a minor increase of lipid peroxides was
observed (Fig. 1B). Therefore, the observed increase in the
cellular content of ROS suggests a role for a redox-sensitive
pathway in DC activation and maturation induced by chemi-
cal sensitizers.
Our results are supported by previous reports showing a
role for ROS in DC activation and maturation, in studies
where human DC activation was induced with LPS (an
immunostimulatory molecule that also induces the maturation




















both cases, the role of ROS was inferred based on the use of
antioxidants, and the presence of ROS or derivatives was not
analyzed. A recent report demonstrating that upon antigen-
specific interaction of DC with T cells, the intracellular





 However, this increase in ROS was detected in the
process of antigen presentation and not during activation of




indicating that the formation of free radicals is important for
DC function.
We previously reported that DNFB activates ERK1/2 and




 Our findings are in agreement with
recent reports showing p38 MAPK phosphorylation in human









Furthermore, we also detected a strong activation of ERK1/2









experiments using human monocyte-derived DC, these two
signalling pathways were also shown to be activated by






















 The activation of p38 MAPK by DNCB was also





Although MAPK participate in different signalling path-
ways, they may be functionally related, and may be coacti-
vated in response to certain stimuli. For example, ERK, JNK





some cases they can be coactivated but may exert opposite





, the ERK pathway has been described as a negative









-derived DC stimulated with nickel,
ERK, JNK and p38 MAPK are activated and cooperate in the























may be partially suppressed and, as a consequence, abrogates





ingly, we observed previously that p38 MAPK inhibits ERK
activation in FSDC, an effect that was suppressed by an
inhibitor of p38 MAPK (SB203580; data not shown). This
suggests that there is a cross-talk between the p38 MAPK and
the ERK pathways, which prevents ERK activity in FSDC
stimulated with DNFB.
Several reports demonstrate that oxidants can activate




 which prompted us to
investigate whether ROS could mediate MAPK activation in
FSDC. Inhibition of protein oxidation with GSH almost
completely inhibited DNFB-induced p38 MAPK and ERK1/2
activation (Fig. 2). In contrast, inhibition of lipid peroxidation




2,4-dinitrofluorobenzene (DNFB) induces oxidation of









Cell lysates were collected at 5, 15 and
30 min after stimulation, derivatized with dinitrophenylhydrazine
and analyzed by western blot using the specific antibody for
dinitrophenyl groups, as described in the Materials and methods.
The specificity of the sensitizing effect of DNFB was tested by





g/mL for 30 min). The results were quantified by
scanning the membrane with a fluorescence scanner and analyzed
using the ImageQuant software. Results are expressed as the fold
increase relative to the control (C) in each experiment. Data are




 SEM of four independent experiments.














collected at 5, 15 and 30 min after stimulation and analyzed by the
thiobarbituric acid (TBA) colourimetric assay for lipid oxidation,
as described in the Materials and methods. Lipid oxidation












mol/L) for 15 min is
shown as a positive control. Results are expressed as fold increase
relative to the control (C) in each experiment. Data are expressed
 




 SEM of four independent experiments. Statistical














Therefore, the increase in ROS induced by DNFB in FSDC
plays an important role in the activation of p38 MAPK and
ERK1/2.
The effect of GSH on MAPK activation is in agreement
with another study where the effect of antioxidants on
tyrosine phosphorylation induced by several sensitizers was
analyzed, using human monocyte-derived DC. In this study,
 
N-acetyl-L-cysteine (NAC; an antioxidant that can act as
precursor for reduced GSH) and GSH inhibited tyrosine
phosphorylation induced by stimulation of the cells with the
sensitizer methylchloroisothiazolinone/methylisothiazolinone
(MCI/MI), whereas vitamin E had no effect.39 Another
recent study also suggested that, as we demonstrated, p38
MAPK activity could be increased by ROS, which mediated
the DNCB-induced phenotypic changes in a BC1 cell line.26
However, in this study the direct effect of ROS on p38
MAPK activation was not investigated. Furthermore, only
NAC was used as an antioxidant.
Figure 2 Reduced glutathione
(GSH) prevents the phosphoryla-
tion of ERK1/2 (A) and p38
mitogen-activated protein kinases
(MAPK) (B) induced by 2,4-
dinitrofluorobenzene (DNFB).
Cells were stimulated or not with
5 µg/mL of DNFB for 15 and
30 min, in the presence or not of
1 mmol/L GSH, and the cell
lysates were collected at the
indicated times after stimulation.
Equal amounts of protein were
loaded on 10% SDS–polyacrilamide
gels, subjected to electrophoresis
and electrotransferred to poly-
vinylidene difluoride (PVDF)
membranes, before probing with
a phospho-specific anti-ERK1/2
antibody (A) or anti-p38 MAPK
antibody (B), as described in the
Materials and methods. The
results were quantified by scan-
ning the membrane with a fluores-
cence scanner and analyzed using
the ImageQuant software. The
results were expressed as the
percentage of phosphorylation
relative to total in each experi-
ment. Data are expressed as the
mean ± SEM of four independent
experiments. Statistical signifi-
cance was calculated by the one-
way anova test with Bonferroni’s
post-test (+P < 0.05, ++P < 0.01,
+++P < 0.001 compared to the
stimulus). C, control.
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CD40 is a membrane-associated receptor that is upregu-
lated in DC during maturation induced by several stimuli,
including skin sensitizers.8,17 In the present work, we found
that the upregulation of CD40 protein levels by DNFB was
only slightly changed in the presence of antioxidants (Fig. 4),
suggesting that other signalling pathways must be involved.
In contrast to our results, one report described that NAC and
GSH reduce CD40 expression on murine DC stimulated with
TNF-α.31 Previous studies showed that CD40 protein levels
are upregulated in FSDC by a mechanism partially dependent
of p38 MAPK, while activation of ERK had no effect.29 This
correlates with previous studies describing no effect of ERK
on DC maturation.7,40,41 However, other studies described a
role for ERK in cytokine release,25 while others described
a role in the downregulation of monocyte-derived DC matur-
ation.34 In FSDC, the role of ERK activation induced by
DNFB remains unclear.
The proinflammatory cytokine IL-1β is one of the first to
be produced by DC42 upon challenge with chemical sensi-
tizers. This cytokine induces the production of ROS43 that act
as an intracellular second messenger mediating the biological
response to IL-1β.44 In addition, ROS are involved in LPS-
mediated regulation of IL-1 expression in macrophages.37
Taken together, these studies suggest that ROS may act to
induce IL-1 production and to mediate its effect. In fact,
DNFB increases production of IL-1β and upregulates IL-1
receptor protein levels in FSDC,45 suggesting that ROS may
be involved in the regulation of both IL-1β production and the
response to the cytokine.
We have previously found that DNFB activates the
transcription factor NF-κB in FSDC.28 Because NF-κB
activation may be regulated by the production of ROS46 in
the immune response, it can be hypothesized that ROS
may be involved in DNFB-induced NF-κB activation in
FSDC.
In conclusion, we have shown that DNFB induces protein
oxidation in FSDC, upstream of the activation of p38 MAPK
and ERK1/2. In contrast, ROS do not seem to play an
important role in DNFB-induced upregulation of CD40
expression. This indicates that the intracellular redox status of
the cell is important in mediating the activation of the MAPK
signalling pathways.
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Figure 3 Vitamin E does not affect significantly the phosphory-
lation of ERK1/2 (A) and p38 MAPK (B) induced by 2,4-
dinitrofluorobenzene (DNFB). Cells were stimulated or not with
5 µg/mL of DNFB in the presence or not of 1 mmol/L vitamin E,
and cell lysates were collected at the indicated times after stimula-
tion. Equal amounts of protein were loaded on 10% SDS–polyacry-
lamide gels, subjected to electrophoresis and electrotransferred to
polyvinylidene difluoride (PVDF) membranes, before probing
with a phospho-specific anti-ERK1/2 antibody (A) or anti-p38
mitogen-activated protein kinase (MAPK) antibody (B), as described
in the Materials and methods. Data are representative of three
independent experiments. C, control.
Figure 4 Vitamin E and glutathione (GSH) partially affect 2,4-
dinitrofluorobenzene (DNFB)-induced increase of CD40 protein
levels in the fetal skin derived dendritic cell (FSDC) line. Cells
were stimulated or not with 5 µg/mL of DNFB in the presence of
vitamin E (1 mmol/L) or GSH (1 mmol/L), and collected after 2 h
of stimulation. Equal amounts of protein were loaded on 10%
SDS–polyacrylamide gels, subjected to electrophoresis and elec-
trotransferred to polyvinylidene difluoride (PVDF) membranes,
before probing with an anti-CD40 antibody. The results were
quantified by scanning the membrane with a fluorescence scanner
and analyzed using the ImageQuant software. The results were
expressed as fold increase relative to the control in each experi-
ment. Data are expressed as the mean ± SEM of four independent
experiments. Statistical significance was calculated by the one-
way ANOVA test with Bonferroni’s post-test (*P < 0.05 compared
to the control).
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